Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
Vito Lorusso National Cancer Research Centre, Istituto Tumori Giovanni Paolo II, Bari, Italy Abstract: As recommended by most recent antiemetic guidelines, the optimal prophylaxis of chemotherapy-induced nausea and vomiting (CINV) requires the combination of 5-HT3 receptor antagonist (RA) with an...
সংরক্ষণ করুন:
| প্রধান লেখক: | |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Dove Medical Press
2016-06-01
|
| মালা: | Therapeutics and Clinical Risk Management |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.dovepress.com/management-of-chemotherapy-induced-nausea-and-vomiting-by-risk-profile-peer-reviewed-article-TCRM |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|